DOSE ESCALATION OF BIOLOGICS IN CROHN'S DISEASE: CRITICAL REVIEW OF OBSERVATIONAL STUDIES

2016 ◽  
Author(s):  
Xin Ying Lee
Keyword(s):  
Crohn’S Disease ◽  
Crohn's Disease ◽  
Dose Escalation ◽  
Critical Review ◽  
Observational Studies

Dose escalation of biologics in Crohn’s disease: critical review of observational studies

2017 ◽  
Vol 33 (8) ◽  
pp. 1433-1449 ◽  
Author(s):  
Thomas R. Einarson ◽  
Basil G. Bereza ◽  
Xin Ying Lee ◽  
Filippo Lelli
Keyword(s):  
Crohn’S Disease ◽  
Crohn's Disease ◽  
Dose Escalation ◽  
Critical Review ◽  
Observational Studies

scholarly journals Dose Escalation of Biologics in Crohn’s Disease: Summary of Observational Studies in the UK

2016 ◽  
Vol 19 (7) ◽  
pp. A509
Author(s):  
M Worbes-Cerezo ◽  
XY Lee ◽  
F Lelli ◽  
BG Bereza ◽  
TR Einarson
Keyword(s):  
Crohn’S Disease ◽  
Crohn's Disease ◽  
Dose Escalation ◽  
Observational Studies ◽  
The Uk

W1106 Increased BMI Is Not Associated with Dose Escalation or Failure of Adalimumab Therapy in Crohn's Disease

2009 ◽  
Vol 136 (5) ◽  
pp. A-655 ◽  
Author(s):  
Bashar Qumseya ◽  
Amar S. Naik ◽  
Ashwin N. Ananthakrishnan ◽  
Yelena Zadvornova ◽  
Susan Skaros ◽  
...  
Keyword(s):  
Crohn’S Disease ◽  
Crohn's Disease ◽  
Dose Escalation ◽  
Adalimumab Therapy

W1093 Predictors and Timing of Adalimumab (ADA) Dose Escalation in Patients with Crohn's Disease (CD)

2009 ◽  
Vol 136 (5) ◽  
pp. A-652 ◽  
Author(s):  
Russell D. Cohen ◽  
Jeffrey R. Lewis ◽  
Hannah Turner ◽  
Stephen B. Hanauer ◽  
David T. Rubin
Keyword(s):  
Crohn’S Disease ◽  
Crohn's Disease ◽  
Dose Escalation

scholarly journals P572 Reactive dose escalation of infliximab in patients with Crohn’s disease in TAILORIX leads to improved outcomes

2018 ◽  
Vol 12 (supplement_1) ◽  
pp. S396-S397
Author(s):  
E Dreesen ◽  
D Laharie ◽  
G Lambrecht ◽  
P Bossuyt ◽  
A Buisson ◽  
...  
Keyword(s):  
Crohn’S Disease ◽  
Crohn's Disease ◽  
Dose Escalation ◽  
Improved Outcomes

scholarly journals Cost savings of anti-TNF therapy using a test-based strategy versus an empirical dose escalation in Crohn's disease patients who lose response to infliximab

2015 ◽  
Vol 3 (1) ◽  
pp. 29229 ◽  
Author(s):  
Xavier Roblin ◽  
Alain Attar ◽  
Michel Lamure ◽  
Bernard Savarieau ◽  
Pierre Brunel ◽  
...  
Keyword(s):  
Crohn’S Disease ◽  
Crohn's Disease ◽  
Dose Escalation ◽  
Cost Savings ◽  
Strategy Versus
Sign in / Sign up

Export Citation Format

Share Document